Bulletin
Investor Alert

Momenta Pharmaceuticals Inc.

NAS: MNTA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200094979/composite

$

32.99

Change

0.00 0.00%

Volume

Volume 20,497

Aug 7, 2020, 4:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200094979/composite

Previous close

$ 32.40

$ 32.99

Change

+0.59 +1.82%

Day low

Day high

$31.88

$33.29

Open
Open: 32.43

52 week low

52 week high

$11.29

$39.88

Open

Market cap

$3.88B

Average volume

1.18M

P/E ratio

N/A

Rev. per Employee

$577,015

EPS

-2.80

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mnta

MarketWatch News on MNTA

  1. Nasdaq maintains first support, S&P 500 rattles the near-term range

    11:55 a.m. June 22, 2020

    - Michael Ashbaugh

  2. Momenta Pharmaceuticals stock price target raised to $43 from $29 at Stifel Nicolaus

    8:56 a.m. Jan. 28, 2020

    - Tomi Kilgore

  3. Momenta Pharmaceuticals stock price target raised to $50 from $29 at SunTrust RH

    8:17 a.m. Jan. 15, 2020

    - Tomi Kilgore

  4. Momenta Pharmaceuticals upgraded to overweight from neutral at J.P. Morgan

    8:10 a.m. Jan. 15, 2020

    - Tomi Kilgore

  5. These Stocks Have the Most to Gain as U.S., China Talk Trade

    7:37 p.m. Jan. 17, 2019

    - Barron's Online

  6. Momenta Pharmaceuticals upgraded to buy from hold at Stifel

    10:27 a.m. Feb. 22, 2018

    - Trey Williams

  7. Teva Tightens Belt, Now a Buy

    11:56 a.m. Jan. 9, 2018

    - Barrons Blogs

  8. Momenta shares plunge 14% on Q3 profit, revenue misses

    8:29 a.m. Nov. 1, 2017

    - Emma Court

  9. Momenta and Mylan say Orencia biosimilar didn't meet primary endpoints in early-stage trial

    8:12 a.m. Nov. 1, 2017

    - Emma Court

  10. Momenta shares plunge 14% on Q3 profit, revenue misses

    8:10 a.m. Nov. 1, 2017

    - Emma Court

  11. Momenta Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    7:30 a.m. Oct. 5, 2017

    - Tomi Kilgore

  12. Momenta Pharmaceuticals stock price target cut to $15 from $22 at Stifel Nicolaus

    7:30 a.m. Oct. 5, 2017

    - Tomi Kilgore

  13. Momenta Pharmaceuticals' stock plunges 26% premarket toward a 10 1/2-month low

    7:55 a.m. Oct. 4, 2017

    - Tomi Kilgore

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mnta

Other News on MNTA

  1. IPO Update: Annexon Proposes IPO Terms

    2:32 p.m. July 20, 2020

    - Seeking Alpha

  2. Annexon Initiates $100 Million IPO Effort

    11:00 a.m. July 11, 2020

    - Seeking Alpha

  3. Top Ranked Momentum Stocks to Buy for July 6th

    7:32 a.m. July 6, 2020

    - Zacks.com

  4. Stifel Nicolaus Believes Momenta Pharma (MNTA) Won’t Stop Here

    5:09 p.m. June 24, 2020

    - SmarterAnalyst

  5. Company News for Jun 16, 2020

    9:58 a.m. June 16, 2020

    - Zacks.com

  6. Small Caps Build Steam And Biotechs Remain Well-Positioned

    10:15 a.m. June 10, 2020

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/mnta

Press Releases on MNTA

  1. Stocks Hit 52-Week High: $SLP $STAA $MNTA

    9:00 a.m. June 16, 2020

    - The Market Signal

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.